Navigation Links
Codexis Names Sarret SVP, Corporate Development
Date:3/18/2009

REDWOOD CITY, Calif., March 18 /PRNewswire/ -- Codexis, Inc. today announced that Joseph Sarret, M.D., J.D., has been promoted to Senior Vice President, Corporate Development from his previous position as Vice President, Corporate Development. He continues to report to Alan Shaw, Ph.D., President and CEO.

Dr. Sarret was named Vice President, Corporate Development in 2007. He joined Codexis in 2005 as Corporate Counsel and Director, Business Development. Previously, he was an associate at Latham & Watkins LLP, where he provided legal services to life sciences companies. He also served as attending physician and later Acting Medical Director for the HIV Clinic at the University of California, San Francisco Medical Center. Dr. Sarret is a graduate of both the University of California, San Francisco School of Medicine and Stanford Law School. He received a bachelor's degree in human biology from Stanford, where he graduated Phi Beta Kappa.

"Under Joe Sarret's leadership, Codexis has established business partnerships with some of the world's premier companies in energy and pharmaceuticals," Dr. Shaw said. "He has played a significant role in the evolution of our biofuels collaboration with Shell, and in successful negotiations with leading life science companies now leveraging Codexis technology in their human therapeutics programs. His continuing contributions to building a strong business base for Codexis are important to maintaining our leadership in clean technology."

Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes. Codexis technology is used in the energy industry to enable next generation, non-food biofuels and by global pharmaceutical companies for cost-effective manufacturing of human therapeutics. Future commercial applications include carbon management, water treatment and chemical manufacturing. For more information, visit www.codexis.com.

    Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or
    Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Irelands Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products
2. New Corporate Agreement with Legacy Hospital Partners, Inc. Names Broadlane Exclusive Provider of Supply Chain and Procurement Services
3. Align Technology Names Sheila Tan as VP, Marketing and Chief Marketing Officer
4. ACP Medicine Names New Editor, Looks Toward Future of Medicine
5. VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer
6. NutraCea Names James C. Lintzenich As Interim CEO
7. Park Springs Names New Medical Director
8. Juvenile Diabetes Research Foundation Names Monye Connolly Corporate Chair for its Annual Walk to Cure Diabetes
9. SilverCensus.com Names Consumer Affairs Advocate, Healthcare Experts to Provide Free Educational Support for Seniors
10. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
11. National Electronic Attachment (NEA) Names EDI Health Group Top Clearinghouse for 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... December 10, 2016 , ... ... Santa are all sources of external stimuli that can put a great deal ... pressure to spread holiday cheer through gifts, food and festive gatherings can lead ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... counseling and aural rehabilitation—provided by audiologists—to remain a critical part of public access ... and Drug Administration (FDA) announced this week that, starting immediately, it ...
(Date:12/9/2016)... ... , ... The Justin Veatch Fund announced Thursday that The ... Whispering Spirits and its discussion guide for use by all of its ... the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy organization ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Compensation Research Institute (WCRI) officially opened registration today for its 33rd Annual ... in Boston, MA . , The theme of the conference is “Persistent Challenges ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... de 2016  A Mederi Therapeutics Inc . anunciou aprovação regulatória, pela ... para a doença do refluxo gastroesofágico (DRGE). Foto -  http://photos.prnewswire.com/prnh/20161207/446903 ... ... Live Stretta procedure performed and broadcast during the Chinese Congress of ... , , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
(Date:12/8/2016)... 2016 True Health Diagnostics today announced ... services and management expertise to hospital systems throughout ... more doctors and patients to benefit from state-of-the-art ... Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... pressure to contain costs, have struggled to keep ...
Breaking Medicine Technology: